Preliminary Program

 ASGT Fifth Annual Meeting
 June 5-9, 2002, Boston

Session Types and their Definitions

Friday, June 7
7:00 am – Noon	Poster Setup by Authors
7:30 am – 5:00 pm	Attendee Registration Open
8:00 am – 10:00 am	4 Scientific Symposia
	Scientific Symposium SS300 Cancer - Immunological Approaches Chair: Stephen L. Eck, MD, PhD Speakers:  Stephen L. Eck, MD, PhD The Alteration of the Immune Response by Tumor Derived Factors Richard G. Vile, PhD Multiple Level Immune Targeting of Metastatic Disease Estuardo Aguilar-Cordova, PhD Principles of Suicide Gene Therapy and Immunology as Shown in Studies of Prostatic Cancer
	Scientific Symposium SS301 Cardiovascular - New Concepts in Cardiovascular Gene Therapy Chair: Todd K. Rosengart, MD Speakers:  Andrea Amalfitano, DO, PhD Treating the Cardiomyopathy of Pompe's Disease with a Safer (and Scaleable) Adenovirus Based Vector Shahin Rafii, MD Recruitment of Bone Marrow Derived Stem Cells for Tissue Vascularization by Adenoviral Vectors Expressing Angiogenic Factors Edith Tzeng, MD Inducible Nitric Oxide Synthase Gene Transfer for Intimal Hyperplasia Peter A. Campochiaro, MD Gene Therapy for Ocular Neovascularization
	Scientific Symposium SS302 Genetic Disease - Stem Cells for Genetic Disease Chair: Donald B. Kohn, MD Speakers:  John E. Dick, PhD Identification of the Correct Target Cell for Stem Cell Based Therapies John H. Wolfe, VMD, PhD Neural Stem Cell Treatment for Global CNS Disease Louis M. Kunkel, PhD Bone Marrow Transplantation for Human Muscular Dystrophy Markus Grompe, MD Liver Repopulation by Extrahepatic Stem Cells
	Scientific Symposium SS303 Viral Gene Transfer - Mechanisms of Transduction Chair: Luigi Naldini, MD, PhD Speakers:  Luigi Naldini, MD, PhD Efficient Delivery, Robust Long-Term Expression, Targeting and Exogenous Regulation of Transgenes In Vivo by Lentiviral Vectors Neal A. Deluca, PhD Virus-Cell Interactions Affecting Transgene Expression from HSV-Vectors John F. Engelhardt, PhD Intracellular Processing of rAAV and Implications for Gene Therapy Thomas Wickham, PhD Developing Genetically Targeted Adenovirus Vectors for Cancer Therapy
10:15 am – 12:15 pm	4 Scientific Symposia
	Scientific Symposium SS310 Ethics - Genetic Enhancement for Athletic Performance Co-Chairs: Theodore Friedmann, MD Johann Olaf Koss Speakers:  Gary I. Wadler, MD Doping in Sport Arne Ljungqvist, MD, PhD Present Problems in Doping - Detection and Screening Barry J. Byrne, MD, PhD Gene Transfer for Sport Enhancement? Johann Olaf Koss Gene Transfer Enhancement in Sport: An Athlete's Perspective Maxwell Mehlman, JD Should Sport Open the Door to Genetic Enhancement?
	Scientific Symposium SS311 Hemopoietic - Hemopoietic Gene Therapy: Progress and Prospects Chair: Richard C. Mulligan, PhD Speakers:  Brian Sorrentino, MD In Vivo Selection for Amplifying Corrected Stem Cells C. Anthony Blau, MD Pharmacologically Regulated Cell Therapy Alain Fischer, MD Gene Therapy of X-linked Severe Combined Immunodefiency - Three Years Later Donald B. Kohn, MD Gene Therapy for Immune Deficiency Diseases
	Scientific Symposium SS312 Neural Disorders - The CNS: Using Gene Delivery to Understand Function and Disease Chair: Howard J. Federoff, MD, PhD Speakers:  Matthew J. During, MD AAV Gene Transfer as a Component of Functional Genomic Studies in the CNS Howard J. Federoff, MD, PhD Dissection of Neurologic Disease Mechanisms by Gene Transfer Evan Snyder, MD, PhD Neural Stem Cells as a Tool for Understanding Some Mechanisms of CNS Repair Bill Hauswirth, PhD AAV-Vectored Gene Therapy for Ocular Neovascularization
	Scientific Symposium SS313 Non-Viral - Recent Advances in Non-Viral Gene Transfer Chair: Seng H. Cheng, PhD Speakers:  Jean-Paul Behr, PhD Cell Targeting with Nanometric DNA Particles Richard Heller, PhD Electrically Enhanced Delivery of Plasmid DNA Grayson B. Lipford, PhD CpG-DNA Signaling via Toll-like Receptor 9 Ernst Wagner, PhD Tumor-Targeted DNA Polyplexes
Noon – 7:00 pm	Poster Viewing (Authors present from 4:00 pm – 7:00 pm)
12:30 pm – 1:30 pm	Meet the Expert Lunches
	Meet the Expert Lunch ME320 AAV Vectors for Gene Delivery Barrie Carter, PhD
	Meet the Expert Lunch ME 327 Cardiovascular Gene Therapy Moving from the Bench to the Clinic Victor Dzau, MD
	Meet the Expert Lunch ME321 Regulatory Compliance for the Vector Production Facility and Gene Therapy Lab Adrian P. Gee, PhD
	Meet the Expert Lunch ME322 Gene Therapy Using HSV Vectors Joseph Glorioso, PhD
	Meet the Expert Lunch ME323 Vaccines and Gene Therapy: Immunological Responses Against the Transgene Margaret A. Liu, MD
	Meet the Expert Lunch ME325 Lentiviral Vectors Inder Verma, PhD
	Meet the Expert Lunch 326 Moving Basic Gene Therapy Science to the Market Samuel C. Wadsworth, PhD
1:45 pm – 4:00 pm	9 Simultaneous Oral Presentations
	Oral Abstract Session OA331 RNA Virus Vectors: Novel Viruses Moderators: Kenneth Cornetta, MD Luigi Naldini, MD, PhD (Abstracts #440 - #447)
	Oral Abstract Session OA332 Advances in HSV-1 Vector Design Moderators: Howard J. Federoff, MD, PhD Samuel Rabkin, PhD (Abstracts #448 - #457)
	Oral Abstract Session OA333 Adenoviral Vectors: Targeting Side Effects, Models Moderators: Daniel A. Muruve, MD Thomas Wickham, PhD (Abstracts #458 - #467)
	Oral Abstract Session OA334 Mechanisms of Naked DNA Gene Transfer Moderators: Bradley L. Hodges, PhD Melinda Lee Lucas, PhD (Abstracts #468 - #472)
	Oral Abstract Session OA336 Gene Transfer for Hemophilia and Other Inherited Diseases Moderators: Linda Couto, PhD Brendan Lee, MD, PhD (Abstracts #478- #487)
	Oral Abstract Session OA337 Cardiovascular Moderators: Frank J. Giordano, MD Katherine Ponder, MD (Abstracts #488 - #495)
	Oral Abstract Session OA338 Chemokine Based Immunotherapy Moderators: Richard G. Vile, PhD TBA (Abstracts #496 - #505)
	Oral Abstract Session OA339 Regulated Gene Expression: Novel Technologies Moderators: Victor Rivera, PhD S. Kaye Spratt, PhD (Abstracts #506 - #515)
	Oral Abstract Session OA335 Gene Therapies and Vaccines Against Infectious Diseases Moderators: Roger J. Pomerantz, MD TBA (Abstracts #473 - #477)
3:00 pm - 7:00 pm	Exhibit Hall Open
4:00 pm – 7:00 pm	Poster Session, Exhibits and Reception
7:00 pm – 10:00 pm	Corporate Symposia
	Corporate Symposium CS340 Biology of Gene Delivery (Supported by Targeted Genetics) Session Chair/Moderator: Barrie J. Carter, PhD Speakers:  Daniel Rader, MD Gene Transfer for Lipid Disorders and Atherosclerosis James Barsoum, PhD Eradication of Local and Distant Tumors via Adenovirus-mediated Interferon-β Gene Therapy Ralph Paul, PhD In Vivo Targeting with LPD and Ligands Seng H. Cheng, PhD  Gene Therapy of the Glycosphingolipid Storage Disorders Fabry and Gaucher John F. Engelhardt, PhD  RNA-mediate Trans-splicing (SmaRT) Approaches for Gene Therapy of Cystic Fibrosis
	Corporate Symposium CS341 Gene Transfer Strategies for Treatment of Neuromuscular Disorders (Supported by Avigen) Session Chair: Alan McClelland, PhD Moderator: Howard J. Federoff, MD, PhD Speakers:  Howard Federoff, MD Introduction Hansell Stedman, MD  The Muscular Dystrophies Krys Bankiewicz, MD, PhD Parkinson’s Disease: Intrastriatal AADC Jeffrey H. Kordower, PhD Parkinson’s Disease: Growth Factor Therapy E. Antonio Chiocca, MD, PhD  Gene Therapy for Stroke

© 2001-2002 All rights reserved. American Society of Gene Therapy